Historical record - last NADAC effective date: 4/20/2022
Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1140 per EA under NDC 69097081903. Its NADAC has been published 290 times since Oct 12, 2016.
FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081903
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/20/2022
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA079162FDA Approved
3/27/2009
TE Code
AB
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 290 times since Oct 12, 2016, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1140 per EA |
|---|---|
| All-time high | $0.1300 (Jan 13, 2021) |
| All-time low | $0.0961 (Apr 18, 2018) |
| Median price | $0.1162 |
| Average price | $0.1134 |
| Largest weekly change | -12.3% (Apr 18, 2018) |
| Weeks tracked | 290 |
| Tracking since | Oct 12, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-2.6%
All
-6.5%
Last surveyed Apr 27, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Cipla USA Inc., is $0.1140 per EA (NDC 69097081903), effective Apr 27, 2022.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 6.5%. It has been tracked across 290 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Oct 12, 2016, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0961 (Apr 18, 2018) to a high of $0.1300 (Jan 13, 2021), with a median of $0.1162 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 23% below TOPIRAMATE 200 MG TABLET.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 69097081903) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.